What are the first line treatment options for acute migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Migraine Treatment

For acute migraine treatment, start with NSAIDs (ibuprofen 400-800 mg, naproxen sodium 500-825 mg, or aspirin 1000 mg) as first-line therapy for mild-to-moderate attacks, and escalate to triptans (sumatriptan 50-100 mg, rizatriptan, or zolmitriptan) for moderate-to-severe attacks or when NSAIDs fail. 1, 2

First-Line Treatment: NSAIDs

Use NSAIDs as the initial treatment for all migraine attacks unless contraindicated. 1

  • Acetylsalicylic acid (aspirin), ibuprofen, and diclofenac potassium have the strongest evidence for first-line use in acute migraine 1
  • Paracetamol (acetaminophen) has less efficacy and should only be used in patients intolerant of NSAIDs 1
  • Administer NSAIDs early in the attack when pain is still mild for maximum effectiveness 1, 2
  • Specific dosing: ibuprofen 400-800 mg, naproxen sodium 500-825 mg, or aspirin 1000 mg at onset 2, 3

Second-Line Treatment: Triptans

Escalate to triptans when NSAIDs provide inadequate relief or for moderate-to-severe attacks. 1

  • All triptans have well-documented effectiveness, with oral sumatriptan 50-100 mg, rizatriptan, and zolmitriptan having the best evidence 1, 2, 4
  • Triptans are most effective when taken early in the attack while headache is still mild 1
  • Do not use triptans during the aura phase - there is no evidence supporting this practice 1
  • If one triptan fails, try others, as failure of one does not predict failure of another 1, 2

Route Selection for Triptans

  • Oral triptans (50-100 mg sumatriptan): Standard route for most patients, with 61-62% achieving headache response at 2 hours 4
  • Subcutaneous sumatriptan 6 mg: Most effective formulation with 59% achieving complete pain relief by 2 hours and fastest onset (15 minutes), but highest adverse event rate 1, 5, 6
  • Intranasal sumatriptan (5-20 mg): Useful for patients with significant nausea/vomiting or rapid progression to peak intensity 2, 7

Combination Therapy for Enhanced Efficacy

Combine triptans with fast-acting NSAIDs (naproxen sodium, ibuprofen lysine, or diclofenac potassium) to prevent relapse and improve outcomes. 1, 2

  • The combination of sumatriptan 50-100 mg PLUS naproxen sodium 500 mg is superior to either agent alone 2
  • This strategy addresses the 40% of patients who experience symptom recurrence within 48 hours 1, 2

Third-Line Treatment

If all available triptans fail after adequate trial (no response in at least three consecutive attacks) or are contraindicated, consider ditans (lasmiditan) or gepants. 1

  • Availability of these agents is currently very limited 1
  • Lasmiditan users should not operate machinery for at least 8 hours after intake 1

Adjunct Medications

Add prokinetic antiemetics for nausea and vomiting during attacks. 1

  • Domperidone or metoclopramide (10 mg) are useful oral adjuncts 1
  • Metoclopramide provides synergistic analgesia beyond antiemetic effects through central dopamine receptor antagonism 2
  • Prochlorperazine (10 mg) is equally effective and has a more favorable side effect profile than chlorpromazine 2

Medications to Avoid

Never use oral ergot alkaloids, opioids, or barbiturates for acute migraine treatment. 1

  • Oral ergot alkaloids are poorly effective and potentially toxic 1
  • Opioids and barbiturates have questionable efficacy, considerable adverse effects, and risk of dependency 1, 2

Critical Frequency Limitation

Strictly limit all acute migraine medications to no more than 2 days per week to prevent medication-overuse headache (MOH). 1, 2

  • Frequent use (>2 days/week) risks development of MOH, leading to daily headaches 1, 2
  • If patients require acute treatment more than twice weekly, initiate preventive therapy immediately 8, 2

Treatment Algorithm by Attack Severity

Mild-to-Moderate Attacks

  1. Start with NSAIDs (ibuprofen 400-800 mg, naproxen 500-825 mg, or aspirin 1000 mg) 1, 2
  2. Add antiemetic if nausea present (metoclopramide 10 mg) 1, 2
  3. If inadequate response after 2-3 attacks, escalate to triptan 2

Moderate-to-Severe Attacks

  1. Start with triptan (sumatriptan 50-100 mg) PLUS NSAID (naproxen 500 mg) 2
  2. Add antiemetic if needed 1
  3. If oral route problematic due to vomiting, use subcutaneous sumatriptan 6 mg 1, 5

Refractory Attacks

  1. Try different triptan if first one fails 1, 2
  2. Consider subcutaneous sumatriptan 6 mg for rapid relief 1, 5
  3. If all triptans fail, escalate to ditans or gepants 1

Common Pitfalls to Avoid

  • Waiting until pain is severe before treating - early treatment when pain is mild significantly improves efficacy 1, 2, 4
  • Repeating the same ineffective triptan - switch to a different triptan after 2-3 failed attempts 1, 2
  • Using acute medications more than 2 days per week - this creates MOH and worsens migraine frequency 1, 2
  • Failing to initiate preventive therapy when patients need acute treatment frequently 8, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Research

Medical Treatment Guidelines for Acute Migraine Attacks.

Acta neurologica Taiwanica, 2017

Guideline

Migraine Prevention Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.